Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 4,976 shares at $40.01 ($199K) on 2017-08-17, disclosed to the SEC on 2017-08-21.
Open-market sale of $199k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.01 | 4,176 | $167K | 83.9% |
| 2 | $40.02 | 800 | $32K | 16.1% |
| Total | $40.01 avg | 4,976 | $199K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |